Lurasidone Linked to Relatively Low Risk for Metabolic Syndrome in Bipolar Depression
Investigators analyzed the potential metabolic effects of lurasidone in a sample of patients with bipolar I depression.
Kwamesha Joseph
Assistant Editor https://www.psychiatryadvisor.com
Kwamesha Joseph is an assistant editor for Endocrinology Advisor, Clinical Pain Advisor, Dermatology Advisor, and The Medical Bag brands of the Haymarket Medical Network. She holds a BA in english with minors in philosophy and African American studies from Fordham University. Prior to joining the network in 2018, Kwamesha interned with PRWeek's Operations and Audience Development team.
